New International Study Highlights High Arterial Clot Risk for Cancer Patients

At the recent European Cardiology Congress in Munich, investigators from the Arterial Cancer Associated Thrombosis initiative presented findings that arterial thrombosis poses a serious risk for individuals with cancer. Led by Grigoris Gerotziapas of INSERM-Sorbonne University, the study found that 8% of cancer patients experienced arterial events such as heart attacks, ischemic strokes, or peripheral artery clots, and another 10% suffered venous thrombosis, meaning roughly one in five patients face some form of clot.

The Greek component, represented by the A' University Cardiology Clinic of EKPA and researchers Konstantinos Toutouzas and Maria Drakopoulou, contributed to a cohort that was predominantly male, median age 65, and largely in advanced disease stages. The consortium, which also includes institutions in Moscow and Chicago, plans to employ artificial-intelligence models to better predict high-risk patients and guide preventive therapies. Experts emphasized that managing traditional cardiovascular risk factors and integrating clot-risk assessment from the time of cancer diagnosis are essential to improve outcomes.